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Sleep quality, the neglected outcome variable in
clinical studies focusing on locomotor system; a
construct validation study
Emin Aghayev1*, Haiko Sprott2, Dieter Bohler1, Christoph Röder1, Urs Müller1
Abstract
Background: In addition to general health and pain, sleep is highly relevant to judging the well-being of an
individual. Of these three important outcome variables, however, sleep is neglected in most outcome studies.
Sleep is a very important resource for recovery from daily stresses and strains, and any alteration of sleep will likely
affect mental and physical health, especially during disease. Sleep assessment therefore should be standard in all
population-based or clinical studies focusing on the locomotor system. Yet current sleep assessment tools are
either too long or too specific for general use.
Methods: Based on a literature review and subsequent patient-based rating of items, an expert panel designed a
four-item questionnaire about sleep. Construct validation of the questionnaire in a random sample of the German-
speaking Swiss population was performed in 2003. Reliability, correlation, and tests for internal consistency and
validity were analyzed.
Results: Overall, 16,634 (70%) out of 23,763 eligible individuals participated in the study. Test-retest reliability
coefficients ranged from 0.72 to 0.87, and a Cronbach’s alpha of 0.83 indicates good internal consistency. Results
show a moderate to good correlation between sleep disturbances and health perception, and between sleep
disturbances and overall pain.
Conclusions: The Sleep Standard Evaluation Questionnaire (SEQ-Sleep) is a reliable and short tool with confirmed
construct validity for sleep assessment in population-based observational studies. It is easy to administer and
therefore suitable for postal surveys of the general population. Criterion validity remains to be determined.
Background
Just as general health and pain are very relevant out-
come variables in judging an individual’s well-being, so
too is sleep. Yet of these three important variables, sleep
is often neglected in outcome studies.
Sleep is a very important resource for recovery from
daily stresses and strains, and its alteration can affect
both mental and physical health [1-6]. Sleep is even
more important during disease. Sleep alterations
increase the pathological significance of any disease and
reduce general well-being [7-10]. Individuals with
altered sleep frequently require pain killers or sleep
medication to get decent sleep. Therapeutic sleep
restoration is often an important condition for the well-
being of patients. Unfortunately, sleep is neglected in
most of the frequently used general quality of life (QoL)
questionnaires such as the SF36 [11,12], EuroQol 5 D
[13], WHODAS II, Health Assessment Questionnaire
[14], McMaster Health Index [15], and WHO-5 [16] or
assessment instruments focusing on the locomotor sys-
tem such as the WOMAC [17], Arthritis Impact Mea-
surement Scales [18], Oswestry Disability Index [19],
and many others. Among frequently used QoL assess-
ment instruments, the Sickness Impact Profile [20], the
WHOQol-100, the Duke Health Profile [21] and the
Nottingham Health Profile [22] include one or more
questions on sleep characteristics, but they are not
meant to be analyzed as an independent dimension of
general health.
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A number of patient-reported sleep measures have
already been published [23]. Measures involving labora-
tory visits, sleep diaries, or actigraphy consume time and
money in clinical trials or population-based studies [24].
Some questionnaires developed for sleep assessment are
quite comprehensive [25-28] and too long to be used as
population-based questionnaires or in clinical trials
where sleep quality is one of many dimensions to be
assessed. The Epworth Sleepiness Scale is a short instru-
ment focusing on only one dimension of the sleep pro-
blem, daytime sleepiness, which therefore makes it
useful only in specific circumstances [29]. The four-item
scale of Jenkins et al. [30], although brief, contains no
questions about either sleep medication or patient-
reported reasons for sleep problems. Such questions are
important in patients with disease of the locomotor sys-
tem because sleep medication is an indicator of the
severity of a sleep problem, and patient-reported reasons
for sleep problems are needed to discriminate between
locomotor, psychological, or other sources of sleep
problems.
The need for a very brief, patient-reported sleep mea-
sure designed for population-based studies or clinical
trials in which sleep is one of several dimensions to be
assessed is clear. Such an instrument will encourage
inclusion of valid sleep items in clinical epidemiological
research. Here we report on the development and con-
struct validation of a Sleep Standard Evaluation Ques-
tionnaire (SEQ-Sleep) using a population-based sample.
SEQ-Sleep can be combined with the previously pub-
lished Pain Standard Evaluation Questionnaire (SEQ-
Pain) [31] or any other questionnaire.
Methods
The Standard Evaluation Questionnaire
The “Standard Evaluation Questionnaire” (SEQ) was
developed in 2003 as part of a nationwide, population-
based survey in the German-speaking area of Switzer-
land [31]. SEQ consists of 43 items relating to different
ICF (International Classification of Functioning, Disabil-
ity, and Health) dimensions [32] such as demographic
variables, pain, activities of daily living (ADL), medica-
tions, need of help, sports, work, smoking and drinking,
social conditions, mental health, and sleep.
Development of the sleep items within the SEQ (SEQ-
Sleep)
Based on a literature review, two questionnaires were
selected for closer scrutiny: the MOS Sleep Scale [28]
and the Pittsburg Sleep Quality Index [25]. All items (n
= 31) relating to sleep viewed from various perspectives
were potentially eligible. Overlapping items were
dropped based on expert opinion [33] (12 items). The
expert panel included a psychologist, two medical
doctors, and a clinical epidemiologist. Retained items
were translated into German and rephrased if necessary
to achieve a standardized format. The pooled sleep
items (n = 19) were then distributed to a set of 20 indi-
viduals to rate each question according to subjective
importance. For the reduction of the questionnaire the
four most important questions (basic questions 1 and 2
selected by the individuals, optional questions 3 and 4
added by the experts) were selected and united with the
rest of the SEQ, and pre-evaluation tests were done
before moving to a pilot study (Figure 1). Question 4
was closely related to question 6 from the Pittsburg
Sleep Quality Index, which was translated to German
and validated [34].
Pilot study
As part of the complete SEQ booklet, the four sleep
items were tested in a pilot study on a mixed sample of
637 individuals (out of 1100 individuals approached)
from 17 institutions (response rate = 58%). 125 of these
participants were enrolled in advanced training courses
at three sport schools (response rate within this sub-
group = 72%), 171 were employees of four commercial
companies (response rate = 67%), 69 lived at homes for
the elderly (response rate = 53%), 161 came from a ter-
tiary care emergency department (response rate = 44%),
and 111 were patients from six orthopedic or rheuma-
tology tertiary care centers (response rate = 64%). The
mean age of participants (53% women) was 47.2 ± 20
and mean body mass index was 23.8 kg/m2 ± 4. Muscu-
loskeletal complaints were reported by 56%, and 9%
were dependent on help for daily living. The first 48
responders were asked to take part in a structured inter-
view aimed at identifying ambiguities in wording and
adapting the relevant items (45, or 94%, participated).
A computer generated random sample of 250 partici-
pants was included in a test-retest study (n = 249; 99%).
The time lag between the two questionnaires was seven
days on average (range 4-11). The intraclass correlation
coefficient (ICC, calculated using bootstrap method for
two-way mixed-effects ANOVA ICC) for the two items
in the sleep sections was 0.84, and weighted kappa coef-
ficients ranged from 0.71 to 0.79 (median 0.78) and
were independent of age, gender, and section.
Participants and mailing procedures during the main
construct validation study
A randomly generated total of 32,440 private households
in the German-speaking part of the Switzerland were
selected from the telephone directory. 8,677 households
were excluded: 5,295 had invalid phone numbers, 2,515
were unable to understand German, 726 individuals liv-
ing alone were reported as deceased, and 141 individuals
were below 18 years of age (Figure 2). A total of 23,763
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households were therefore eligible for a telephone inter-
view and 21,377 (90%) of these were contacted between
November 2002 and June 2003. Potential participants
were informed about the study and consent to receive a
postal questionnaire was obtained. In multiple-member
households, the last-birthday selection technique was
used in analogy to the next-birthday method to identify
one participant per household aged 18 years or older
who was able to understand German [35]. Overall,
17,341 of the 21,377 individuals (81%) consented to par-
ticipate during the telephone interview. A cover letter
with additional study information, a questionnaire, and
a prepaid return envelope were then sent to them.
About 10% (2386) of the 23,763 households could not
be reached by phone after a maximum of 12 attempts
and were contacted by mail using an extended cover let-
ter. Nonresponders were sent a reminder letter after
three weeks, or after six weeks a reminder letter, the
questionnaire, and a prepaid return envelope were deliv-
ered by priority mail.
Testing and validation
The stepwise approach described by Streiner & Norman
[36] and Veenhof et al. [37] was used to select and eval-
uate items. More precisely, item selection for the defini-
tive questionnaire was a three-step procedure relying
upon 1) test-retest reliability (intra-item reliability), 2)
inter-item correlations or redundancy, and 3) Pearson
product-moment correlation between sleep items, pain
intensity (relevancy), and general health. The first ques-
tion of the SF-12 questionnaire was used as the general
health measure (“In general, would you say your health
is?”). All steps were performed in all samples, with a
subsequent sensitivity analysis restricted to individuals
reporting pain in any location on the numeric rating
scales in the original Standard Evaluation Questionnaire.
Test-retest reliability
The test-retest reliability was assessed by sending a sec-
ond questionnaire to the first 170 responders within a
scheduled interval of 7 to 14 days as described by
Figure 1 Final screening tool for evaluation of Sleep (English version not validated yet). The answers of the first two mandatory questions
are summed to a score (0 = normal sleep, 12 = fully disturbed sleep resulting in severe daytime tiredness). The facultative question 3 asks for
the reason sleep is affected, and the facultative question 4 inquires about sleep medication. Questions 3 and 4 are not part of the summed
score.
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Müller et al. [31]; ICCs and weighted kappa statistics
were used. Values larger than 0.60 were considered to
be substantial [38] and items were discarded if the esti-
mated ICCs or kappa values were below 0.60 [39].
Inter-item correlation
Potential redundancy between items extracted from the
same domain was identified by assessing the correlation
between items. If Pearson product-moment correlation
between any two items was larger than 0.75, one of the
items was discarded.
Internal consistency
Cronbach’s alpha was determined for the scale as a mea-
sure of overall consistency of the two items, and the
item total correlation between each item and the total
score was calculated.
Association with intensity of pain and general health
perception (relevancy)
We aimed to show the relevancy of musculoskeletal
pain problems to sleep. Measurement of overall pain in
different body regions was conducted by using the same
distinction described by Müller et al. [31] and the maxi-
mum reported value was used. For example, if an indivi-
dual reported a pain rating of six in the right leg and
three in the back, a rating of 6 was assigned. The Pear-
son product-moment correlation coefficient was used to
determine correlations between ratings of the higher
pain reported in body regions (head and face, upper
Figure 2 Study flowchart.
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extremity, neck and back, chest and stomach, lower
extremity) and the ratings of other, remaining items to
determine the relevancy of the items for pain. Items
were discarded if the correlation coefficient was below
0.25. Additionally, some descriptive statistics will be
reported to support the relevancy of measuring sleep
perception.
The relationship between musculoskeletal pain and
sleep problems was analyzed. Comparison of patients
with pure musculoskeletal pain with and without sleep
problems was performed using a Chi-square test.
For assessment of the sincerity and accuracy of the
participants in answering question 3, their answers were
compared to reported pain intensity.
General issues
Responses were digitized by an independent institution
using optical character recognition and all analyses were
performed in Stata 10.0.
Results
Characteristics of participants
Of the 23,763 individuals eligible for a telephone inter-
view, 16,634 (70%) responded while 4,036 (17%)
declined participation during the phone interview;
3,093 (13%) failed to return the questionnaire. No
information on pain was provided in 443 question-
naires that therefore were excluded from the analysis.
The exclusion of those patients did not significantly
change the distributions of patients among the various
groups of different patient characteristics. 264 of the
16,191 individuals (1.6%) did not fully complete the
SEQ-Sleep (Figure 2). Participant characteristics are
presented in table 1. Mean age was 49.1 ± 16.9 years,
the mean body mass index was 24.5 ± 4.2, and 58%
were women.
Test-retest reliability
The second test-retest study questionnaire was by
returned by 118 (69%) of the first 170 responders within
5 to 13 days (median 11); 77 (65%) of these were
women with a mean age of 52.2 ± 16.0 years. The ICC
between the original and retest ratings for item one was
0.87 and 0.85 for item two. The median kappa value
between the original and the retest item was 0.78 for
question three and 0.72 for question four, exceeding the
lower limit for inclusion of 0.60.
For the subsample of patients with sleep problems due
to musculoskeletal pain, the ICC between the original
and retest ratings for item one was 0.83 and 0.84 for
item two. The median weighted kappa value between
the original and the retest item was 0.77 for question
three and 0.74 for question four.
Inter-item correlation: Redundancy
Inter-item correlations of questions 3 and 4 were mod-
erate both for the overall sample (0.71) and those
reporting pain (0.70). All values were below the upper
bound for inclusion of 0.75.
Internal consistency
We analyzed internal consistency for variables one and
two (sleep quality and the effects of sleep problems on
fatigue) using Cronbach’s alpha as well as the item total
correlation between each item and the sleep score
(Table 2). The values can be considered to be high,
especially since only two items were used.
Association with intensity of pain and general health
perception: relevancy
Pearson product-moment correlation coefficients
between quantitative items of sleep with the overall
intensity of pain and general health were moderate
(Table 3). The correlation between sleep problems and
pain intensity increased to 0.71 if calculated for the sub-
collective indicating bodily pain as the primary reason
for disturbed sleep (n = 899). Back pain was the main
source of sleep disturbance in this sample (Figure 3).
The relationship between sleep problems and muscu-
loskeletal pain is shown in table 4. The table shows a
significantly higher proportion of patients with pure
musculoskeletal pain with sleep problems because of
pain (95%) in comparison with the patients with sleep
problems due to reasons other than pain (86%), or with
the patients without sleep problems (88%) (chi-square
test: p > 0.001). The highest pain intensity of 3.5 points
was seen in patients with sleep problems because of
pain and the lowest (5.7 points) in patients without
sleep problems (Table 4).
Discussion
Summary
The brief Sleep Standard Evaluation Questionnaire,
which includes four items to assess sleep in population-
based observational studies, was developed and vali-
dated. The questionnaire accounts for sleep and its
influence on daytime activity (mandatory questions),
reasons for sleep problems and frequency of sleep medi-
cation (facultative questions). These were shown to be
reliable and valid in a large, representative sample of the
general Swiss population.
Strengths and weaknesses
Items selected for inclusion in the questionnaire were
extracted from scales previously developed for sleep
assessment in clinical trials [25,28]. We did not include
items from sleep-assessment scales used in other medical
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specialties (e.g. neurology or oncology), nor did we
develop any new items. According to the guidelines for
assessing the quality of scales, a set of patients was
involved in the selection of items to be included in the
questionnaire [37,39]. A pool of items was proposed by a
group of experts from a literature review based on two
frequently used sleep questionnaires. Patients’ pre-
evaluation of the subjectively important sleep items
allowed for subsequent reduction of the number of items
to a minimum set of four questions. The subsequent
study drew a large number of participants from the gen-
eral population and was not restricted to individuals
experiencing disturbed sleep. The validation study also
included a sizeable subsample used for calculating test-
retest reliability 15% of the participants reporting sleep
problems cited bodily pain as the reason for their sleep
Table 1 Characteristics of participants
Participants included in
analyses
(n = 16’191)
Participants reporting sleep
problems
(n = 8297)
Participants reporting
pain
(n = 10’610)
Females (n[%]) 9256 (58%) 4923 (59%) 6316 (60%)
Age band (n[%])
18 to 34 years 3554 (23%) 1812 (22%) 2194 (21%)
35 to 44 years 3691 (23%) 1937 (23%) 2393 (23%)
45 to 54 years 2797 (18%) 1488 (18%) 1901 (18%)
55 to 64 years 2522 (16%) 1369 (16%) 1782 (17%)
65 to 74 years 1957 (12%) 969 (12%) 1306 (13%)
75 to 84 years 1136 (7%) 678 (8%) 718 (7%)
85 years and above 220 (1%) 94 (1%) 127 (1%)
Body mass index
Less than 25 kg/m2 9728 (62%) 5045 (62%) 6239 (60%)
25 to 30 kg/m2 4633 (29%) 2323 (29%) 3098 (30%)
30 kg/m2 and above 1441 (9%) 771 (9%) 1036 (10%)
Highest educational level (n[%])
Compulsory schooling/vocational
training
9760 (61%) 4843 (59%) 6364 (60%)
High school graduation 2141 (13%) 1181 (14%) 1476 (14%)
Technical college/university degree 4290 (26%) 2273 (27%) 2850 (27%)
Living independently (n[%]) 15’140 (93%) 7641 (92%) 9876 (92%)
Rural residence* (n[%]) 11’694 (74%) 6089 (73%) 7765 (75%)
Reported sleep problems (n[%]) 8297(51%) 8297(100%) 6247 (59%)
Reported reason for sleep problems (n[%])
Because of bodily pain 1271 (8%) 1271 (15%) 1127 (11%)
Because of other bodily problems 407 (3%) 407 (5%) 340 (3%)
Because of psychological problems 1572 (10%) 1572 (19%) 1259 (12%)
Because of other problems 5047 (30%) 5047 (61%) 3521 (33%)
Reported complaint or condition (n[%])
Musculoskeletal 9603 (59%) 5529 (67%) 8583 (80%)
Visual or hearing 5946 (37%) 3340 (40%) 4296 (40%)
Cardiovascular 2771 (17%) 1480 (18%) 1946 (18%)
Nervous system 4346 (27%) 2737 (33%) 3640 (34%)
Respiratory system and allergies 4051 (25%) 2281 (27%) 2877 (27%)
Mental 1434 (9%) 1078 (13%) 1151 (11%)
Gastrointestinal 1886 (12%) 1276 (15%) 1620 (15%)
Diabetes 472 (3%) 241 (3%) 319 (3%)
Renal 390 (2%) 237 (3%) 291 (3%)
Neoplasia 446 (3%) 256 (3%) 328 (3%)
Currently smoking (n[%]) 4078 (26%) 2086 (25%) 2702 (26%)
No sleeping problems 8197 (50%) 0 (0%) 4354 (41%)
* Village of less than 10’000 inhabitants.
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Table 3 Relevance: How does the sleep score correlate with overall pain and general health?
Relevancy: Pearson product-moment correlation
coefficients
All
participants
(n = 16’191)
Participants
reporting pain
(n = 10’610)
Participants with sleep
problems only because
of bodily pain
(n = 899)
Overall
pain
General
health
Overall
pain
General
health
Overall
pain
General
health
Sleep 0.34 0.33 0.30 0.32 0.71 0.4
Sleep quality 0.33 0.34 0.29 0.33 0.69 0.36
Effects of sleep problems on fatigue 0.30 0.27 0.27 0.26 0.68 0.32
Figure 3 Frequency of pain locations (n = 2631) in the 1271 individuals that suffered from sleep reduction because of bodily pain.
Table 2 Internal consistency regarding to the overall sample and the subsample reporting bodily pain (Internal
consistency: Cronbach’s alpha of the first two items building the total score)
Consistency: Modalities and characteristics of the sleep items All
participants
(n = 16’191)
Participants
reporting
pain
(n = 10’610)
Participants with sleep
problems only because
of bodily pain
(n = 899)
ICC Cronbach’s a ICC Cronbach’s a ICC Cronbach’s a
Sleep 0.83 0.82 0.79
Sleep quality 0.89 0.89 0.85
Effects of sleep problems on fatigue 0.86 0.85 0.83
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problems, while 11% of those reporting pain cited pain as
the origin of sleep disturbance (Table 1). These figures
draw upon a population-based sample in which the
majority of persons report only low-level pain and
patients with severe pain are rare [31]. It is expected that
patients with severe pain will report a higher percentage
of sleep disturbances due to bodily pain.
The median duration of 11 days between the completion
of the first and second questionnaires in the test-retest
study may be too long for assessing the reliability of sleep
assessments since acute sleep disturbance episodes could
have occurred or sleep quality may have changed during
this period. However, test-retest reliability was high for all
items. Our questionnaire covers participant experience
during the previous four weeks. Acute episodes of
increased sleep disturbances and variations in sleep medi-
cations might therefore have been unlikely to be detected.
Concurrent validity criterion with respect to other
sleep questionnaires was not assessed in our study set
up. Our validation study has therefore preliminary
character.
As in other surveys, women and individuals with
higher education were overrepresented in our study
[40]. Other demographic characteristics differed only
slightly between our sample and the general Swiss popu-
lation. The overall response rate in this sample of the
general population was 70%, which is higher than other
studies [41,42]. The proportion of fully completed ques-
tionnaires also was high, indicating that participants
carefully responded to the questions. Both of these facts
confirm the quality of the data and the suitability of our
questionnaire for population-based observational studies.
Although the development of the SEQ-Sleep was based
on a large population-based sample, it is from only one
country with one language. Its transferability to other
countries and languages remains unclear.
Context
Other sleep assessment tools cited above were developed
specifically for clinical trials and are not particularly
recommended for population-based observational studies
[23]. The MOS Sleep Scale, for example, may be used for
sleep assessment in restless leg syndrome [43], diabetic
peripheral neuropathy [44], neuropathic pain [28], or
cancer pain [28,45] where specific sleep assessment is
required. Some questionnaires, e.g., the MOS Sleep scale,
can be definitively applied for an unspecific sleep assess-
ment. But to our knowledge there is no other short and
easy to administer sleep assessment instrument available
for the assessment of sleep regardless of the underlying
pathology that can provide patient-reported reasons for
the sleep problems (e.g., locomotor system pain).
The relationship between general health perception
and sleep is expectedly high [46]. Empirically, the
restoration of healthy sleep conditions in patients has a
high impact on their general health and quality of life
perception. This relationship is supported by our results,
but needs further investigation.
The patients with sleep problems because of pain have
significantly more pure musculoskeletal pain in compar-
ison with the other patients. This underlines important
relationship between disturbed sleep and musculoskele-
tal pain and reasons the use of sleep as an outcome
variable in clinical studies on the locomotor system.
Implications for future studies
For the concluding validation, concurrent validity criter-
ion needs to be determined. Our questionnaire was
developed for population-based cross-sectional studies
of sleep assessment, but it also could be used in clinical
trials and other longitudinal studies. This questionnaire
might also be useful in evaluating patients in routine
clinical practice and in computer-assisted telephone sur-
veys. Additional study would be required to evaluate the
usefulness and psychometric properties of the question-
naire in these settings, even if they might differ only
slightly. Our study being restricted to Switzerland and
its German-speaking population, the transferability of
the questionnaire to other countries and languages
needs to be examined. While a validation of the French
version is currently underway, future studies also should
include validations of English and Spanish translations.
Table 4 Relationship between sleep problems and musculoskeletal pain
N of patients
with pain (%)
N of patients
without pain (%)
Proportion of patients with
pure musculoskeletal pain
Pain intensity (scale: between
1-strong and 7-none)
- No sleep problems 4786 (59%) 3396 (41%) 88% 5.7
- Sleep problems not because of
pain
4900 (77%) 1429 (23%) 86% 4.9
- Sleep problems because of pain 1224 (96%) 47 (4%) 95% 3.5
- Sleep problems because of pain
(ex. confounding causes*)
899 (96%) 32 (4%) 95% 3.6
In patients with sleep problems because of pain a significantly higher proportion of patients with pure musculoskeletal pain (95%) in comparison with the
patients with sleep problems due to reasons other than pain (86%) or with the patients without sleep problems (88%) was seen (p > 0.001). Similar results show
patients with sleep problems because of pain without confounding causes (* - patients with the reason for sleep loss other than pain are excluded).
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Finally, the association between measures derived from
our questionnaire and physical or mental conditions
merits further study.
Conclusions
The Sleep Standard Evaluation Questionnaire is a reli-
able and short tool with confirmed construct validity for
sleep assessment in population-based observational stu-
dies. It is easy to administer and therefore suitable for
postal surveys of the general population. The performed
validation has preliminary character as the concurrent
validity criterion with respect to other sleep question-
naires is not yet determined.
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